There is a reason the world calls India its pharmacy. When a hospital in Nairobi needs a consistent antibiotic supply, when a government tender in Iraq requires thousands of units of cardiovascular generics, or when a distributor in Libya is looking for a certified and affordable medicine partner, the search almost always leads back to India.
At Afif Overseas Pvt. Ltd., we sit right at the heart of that story. Based in Ahmedabad, one of India’s most active pharmaceutical manufacturing hubs, we are a trusted pharmaceutical export company connecting importers and distributors across the world with the medicines their markets depend on.
This blog walks you through exactly why sourcing from India makes business and healthcare sense, and why Afif Overseas is the partner that can make it happen for you.
India exported USD 30.5 billion worth of pharmaceuticals in FY2025, a nearly 16-fold increase from USD 1.9 billion in 2001. That growth is not accidental. It is the result of decades of investment in quality, scale, and reliability.
India Has Earned Its Place as the World’s Generic Medicine Capital
The numbers alone tell a compelling story. India is the third largest pharmaceutical producer in the world by volume. The country manufactures over 60,000 generic brands across 60 therapeutic categories and accounts for roughly 20 percent of the global supply of generic medicines. More than 200 countries receive pharmaceutical products from Indian manufacturers, and that includes the most regulated markets in the world such as the United States, the United Kingdom, and the European Union.
What makes India exceptional is not just the volume but the consistency of quality at scale. Indian pharmaceutical companies have invested heavily in infrastructure, quality control systems, and regulatory compliance over the past two decades. The result is an industry that can match Western manufacturing standards while delivering products at a fraction of the price.
For importers and distributors operating in price-sensitive markets, this combination is nearly impossible to replicate elsewhere.
Why Ahmedabad Specifically Matters
When you partner with Afif Overseas, you are not just working with a pharmaceutical exporter. You are tapping into one of the most concentrated pharmaceutical manufacturing ecosystems in the world.
Ahmedabad and the broader Gujarat region account for a substantial share of India’s total pharmaceutical output. The city is home to hundreds of WHO-GMP certified manufacturing facilities, API producers, and formulation plants across virtually every therapeutic segment. Proximity to these facilities means faster turnaround times, tighter quality oversight, and the ability to source a diverse product range under one supply relationship.
Whether you need oral solids, injectable formulations, dry syrups, or bulk APIs, the manufacturing capability exists within our network in Ahmedabad.
What Sets Afif Overseas Apart from Other Indian Exporters
India has thousands of pharmaceutical exporters. So the right question is not just why India, but why Afif Overseas. Here is what we bring to the table:
- Curated manufacturer network: We work exclusively with WHO-GMP certified manufacturing partners, so every product leaving our supply chain meets international regulatory standards.
- Wide product portfolio: Our range spans antibiotics, cardiovascular drugs, antidiabetics, respiratory medicines, oncology generics, pediatric formulations, OTC products, and APIs. If your market needs it, we can source it.
- Documentation support: From Certificates of Analysis and GMP compliance letters to product dossiers and stability data, we handle the paperwork that matters for Ministry of Health registrations in your country.
- Custom packaging and labeling: We offer local language labeling, blister pack configurations, and private label options tailored to your market requirements.
- Flexible minimum order quantities: Whether you are fulfilling a large government tender or building a private distribution network, we scale to fit your order size.
- Reliable logistics: We work with freight partners experienced in pharmaceutical shipments to the Middle East, Africa, and Southeast Asia, including cold-chain compliance for temperature-sensitive products.
The Markets We Serve
Afif Overseas actively exports to pharmaceutical importers and distributors across the Middle East, North Africa, Sub-Saharan Africa, Southeast Asia, and Central Asia. We have particular expertise in markets such as Libya and Iraq, where demand for high-quality generic medicines continues to grow alongside healthcare infrastructure development.
In these markets, the need for trusted, certified, and consistently available medicines is not a commercial nicety. It is a healthcare necessity. That is precisely where we focus our energy.
Quality You Can Verify
Every product we export comes from manufacturing facilities with documented regulatory approvals. We do not simply quote certifications on paper. We encourage our partners to request audit reports, sample CoAs, and facility compliance documentation before placing their first order. We believe trust is built through transparency, not promises.
Our manufacturing partners hold approvals from WHO-GMP, USFDA, and in many cases EMA and MHRA as well. These are not formalities. They represent thousands of hours of inspection, documentation, and process validation that give you real confidence in what you are importing.
Over 80 percent of the antiretroviral drugs used globally to fight HIV are supplied by Indian manufacturers. India does not just talk about affordable healthcare. It delivers it at scale.
The Cost Advantage Is Real and Sustainable
One of the most common questions importers ask is whether Indian generic prices are competitive in the long term or whether they reflect a short-term pricing strategy. The answer is structural.
India’s cost advantage in pharmaceutical manufacturing comes from a combination of lower input costs, a large and skilled scientific workforce, high production volumes, and decades of process chemistry expertise. These are not factors that change overnight. Indian manufacturers can deliver WHO-GMP certified products at prices 30 to 70 percent lower than equivalent European or North American sources, and that gap has been maintained consistently over years.
For distributors managing tight margins, or for procurement teams trying to stretch government healthcare budgets further, this advantage translates directly to better outcomes.
Start Your Sourcing Conversation Today
If you are a pharmaceutical importer or distributor looking to build a reliable supply relationship with a certified Indian exporter, Afif Overseas Pvt. Ltd. is ready to work with you.
We believe great partnerships start with honest conversations. Tell us what your market needs, the therapeutic areas you cover, your order volumes, and your documentation requirements, and we will put together a sourcing proposal that works for you.
Get in touch with Afif Overseas Pvt. Ltd.
Phone: +91 99790 15551 | Email: info@afifoverseas.com | Website: www.afifoverseas.com | Ahmedabad, Gujarat, India
